| Serial Number | 79432114 |
| Word Mark | NMD PHARMA NEUROMUSCULAR DISORDERS |
| Filing Date | Tuesday, July 15, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Sunday, January 18, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Scientific and technological services and research, namely, research in the field of medicine and the development of pharmaceutical preparations; industrial analysis and research services in the field of development of pharmaceutical preparations, and in the field of identification of drug candidates; drug discovery services; basic research and clinical research, hereunder in the field of medicine and vaccine development; development of medical treatments related to rare and genetic diseases; development of medical treatments related to neurodegenerative diseases; development of medical treatments related to neuromuscular disorders; development of medical treatments that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; development of medical treatments for acute hospital care. |
| Description of Mark | The mark consists of the letters "NMD" in dark grey with a green diamond over the letter "M" followed by the word "PHARMA" in light grey over the wording "NEUROMUSCULAR DISORDERS" in light grey. |
| Pseudo Mark | NEUROMUSCULAR DISORDERS PHARMA NEUROMUSCULAR DISORDERS |
| Goods and Services | Preparations for pharmaceutical purposes, preparations for medical purposes, chemical-pharmaceutical preparations, diagnostic preparations for medical purposes, reagents for medical purposes, preparations for analysis for medical purposes; pharmaceutical and medical preparations for the treatment of rare and genetic diseases; pharmaceutical and medical preparations for the treatment of neurodegenerative diseases; pharmaceutical and medical preparations for the treatment of neuromuscular disorders; pharmaceutical and medical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders, pharmaceutical and medical preparations for acute hospital care |
| Indication of Colors claimed | The color(s) grey, white and green is/are claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 8, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, November 8, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NMD Pharma A/S |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DK |
| Event Date | Event Description |
| Thursday, September 4, 2025 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
| Saturday, November 8, 2025 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Monday, November 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 10, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, December 3, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, December 3, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, December 4, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sunday, January 18, 2026 | REFUSAL PROCESSED BY MPU |
| Monday, January 19, 2026 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, February 12, 2026 | REFUSAL PROCESSED BY IB |
| Thursday, March 12, 2026 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, March 12, 2026 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, March 12, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, March 12, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, March 12, 2026 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |